ライフサイエンスコーパス: cloacae

1 n of their endophytic bacteria (Enterobacter cloacae).

2 of M. morganii, C. freundii, E. coli, and E. cloacae).

3 injection of prepupae with live Enterobacter cloacae.

4 ical to plasmid pNDM-HF727 from Enterobacter cloacae.

5 segment (D-limited mice), with Enterobacter cloacae.

6 -1,3 dextran (DEX) expressed on Enterobacter cloacae.

7 r spp., P. aeruginosa, K. pneumoniae, and E. cloacae.

8 revealed that the organism was Enterobacter cloacae.

9 or treatment of infections with Enterobacter cloacae.

10 ri but 97.0% similar to that of Enterobacter cloacae.

11 eding, restored the immunity to Enterobacter cloacae.

12 o case patients yielded S. marcescens and E. cloacae.

13 most laboratories recognized as Enterobacter cloacae.

14 re Pseudomonas aeruginosa (22), Enterobacter cloacae (21), Acinetobacter spp. (13), Enterobacter aero

15 Klebsiella pneumoniae (14.2%), Enterobacter cloacae (9.1%), Acinetobacter spp. (6.2%), Serratia marc

16 nterpretive criteria, excluding Enterobacter cloacae (98.3% S) and E. faecalis (86.0% S), and MIC(90)

17 hia coli, Klebsiella pneumonia, Enterobacter cloacae, Acinetobacter baumannii, and methicillin-resist

18 Colonization of E. cloacae also reduced HuNoV titers in intestinal tissues

19 ortant enzymes CTX-M-15, KPC-2, Enterobacter cloacae AmpC, Pseudomonas aeruginosa AmpC, OXA-10, and O

20 ed for the class C enzymes from Enterobacter cloacae and Citrobacter freundii.

21 this study involving clinical isolates of E. cloacae and E. aerogenes, susceptibility testing methods

22 l biosynthetic enzyme MurA from Enterobacter cloacae and Escherichia coli in vitro.

23 vivo, we colonized gnotobiotic pigs with E. cloacae and inoculated pigs with 2.74 x 10(4) genome cop

24 A case of ventriculitis due to Enterobacter cloacae and Pseudomonas fulva following placement of an

25 teremia, and seven of these had Enterobacter cloacae and S. marcescens in the same culture.

26 , approximately 10,000 nM), and Enterobacter cloacae and Serratia marcescens were highly resistant (I

27 la pneumoniae, one (<1%) of 890 Enterobacter cloacae, and one (1%) of 162 Enterobacter aerogenes.

28 trains), Klebsiella pneumoniae, Enterobacter cloacae, and Pseudomonas aeruginosa.

29 a coli, Pseudomonas aeruginosa, Enterobacter cloacae, and Yersinia enterocolitica.

30 An outbreak of S. marcescens and E. cloacae bacteremia in a surgical intensive care unit was

31 s were chemically conjugated to Enterobacter cloacae beta-lactamase (bL), and their abilities to effe

32 wever, in our institution the MIC(90) for E. cloacae bloodstream isolates is 16 microg/ml.

33 genes revealed that one-third (15/45) of E. cloacae bloodstream isolates produced SHV-type extended-

34 several Gram-negative bacteria including E. cloacae but not against Gram-positive bacteria.

35 o effectively blocked adhesion of pili or E. cloacae, but no effect was observed with nonspecific ant

36 ndicates extensive dissemination of these E. cloacae clones across the UK and Ireland.

37 uNoV in gnotobiotic pigs, with or without E. cloacae colonization.

38 s, reduced HuNoV shedding was observed in E. cloacae colonized pigs, characterized by significantly s

39 In both control and E. cloacae colonized pigs, HuNoV infection of enterocytes w

40 terminant was highly conserved within the E. cloacae complex and mediated resistance to up to 600 muM

41 sing clinical importance of the Enterobacter cloacae complex have often been discussed.

42 3 nonduplicate Enterobacter isolates (102 E. cloacae complex, 41 E. aerogenes) were tested, including

43 a coli, Enterobacter aerogenes, Enterobacter cloacae complex, Klebsiella pneumoniae, or Klebsiella ox

44 vast majority of clinical isolates of the E. cloacae complex, predominantly in (sub)species that freq

45 inically most prevalent subspecies of the E. cloacae complex.

46 cus aureus, and aac(3)-VIa from Enterobacter cloacae (conferring resistance to kanamycin, spectinomyc

47 ates of Serratia marcescens and Enterobacter cloacae, demonstrating the presence of in-frame translat

48 freundii, Clostridium species, Enterobacter cloacae, Enterococcus faecalis, Klebsiella oxytoca, Kleb

49 nterobacteria Escherichia coli, Enterobacter cloacae, Erwinia herbicola, and Salmonella typhimurium.

50 r pathogenic bacteria including Enterobacter cloacae, Escherichia coli J96, Pseudomonas aeruginosa, p

51 important Gram-negative species-Enterobacter cloacae, Escherichia coli, Klebsiella pneumoniae, and Ps

52 The Enterobacter cloacae GC1 enzyme is an example of a class C ES beta-la

53 ystallographic structure of the Enterobacter cloacae GC1 extended-spectrum class C beta-lactamase, in

54 The beta-lactamase of E. cloacae GC1, an extended spectrum mutant of the P99 enzy

55 the nitroreductase enzyme from Enterobacter cloacae has been determined for the oxidized form in sep

56 Enterobacter cloacae has been implicated as one of the causative agen

57 tly, enteric commensal bacteria Enterobacter cloacae has been recognized as a helper in HuNoV infecti

58 After E. cloacae immunization, MZ B cells were responsible for th

59 raocular infection secondary to Enterobacter cloacae infection is a devastating disease which, despit

60 bleb-related endophthalmitis secondary to E. cloacae infection.

61 population underlies multidrug-resistant E. cloacae infections within hospitals.

62 In summary, E. cloacae inhibited HuNoV infectivity, and B cells were no

63 H2O2 in the leaves of plants 3h after the E. cloacae inoculation, according to a mechanism involving

64 Enterobacter cloacae is a clinically important Gram-negative member o

65 We describe an Enterobacter cloacae isolate harbouring a minor subpopulation that is

66 tematic collection of multidrug-resistant E. cloacae isolated between 2001 and 2011 from bloodstream

67 ion) was achieved in only 76/114 (67%) of E. cloacae isolates (65 susceptible, 11 resistant).

68 and 7 previously determined PB-resistant E. cloacae isolates from JMI Laboratories.

69 enes isolates and 6.0% of the results for E. cloacae isolates tested with the Vitek system.

70 3 Escherichia coli isolates, 5 Enterobacter cloacae isolates, 2 S. marcescens isolates, 1 Proteus mi

71 All but two of the ESBL-producing E. cloacae isolates, but none of the non-ESBL-producing str

72 hods were generally unreliable with these E. cloacae isolates.

73 reevaluation of cefepime breakpoints for E. cloacae may be prudent.

74 ructures of the D305A mutant of Enterobacter cloacae MurA and the D313A mutant of Escherichia coli Ar

75 icted the Cys-115-PEP adduct of Enterobacter cloacae MurA in various reaction states by X-ray crystal

76 Cys115 of Escherichia coli and Enterobacter cloacae MurA is the active site nucleophile alkylated by

77 ined to be 8.3, by titration of Enterobacter cloacae MurA with the alkylating agent iodoacetamide as

78 tructure of the C115S mutant of Enterobacter cloacae MurA, which was crystallized in the presence of

79 Escherichia coli (n = 149), and Enterobacter cloacae (n = 110).

80 coccus epidermidis (n = 100) or Enterobacter cloacae (n = 60).

81 ichia coli (n = 129, 30.0%) and Enterobacter cloacae (n = 62, 14.4%) were the main Enterobacteriaceae

82 avin mononucleotide cofactor of Enterobacter cloacae nitroreductase (NR), determined under a variety

83 Thus E. cloacae NR is not a good candidate for enzymatic product

84 insensitive nitroreductase from Enterobacter cloacae (NR) catalyzes two-electron reduction of nitroar

85 Catheter infection with E. cloacae occurred in 50% of roll plates and 80% of broth

86 To test the influences of E. cloacae on HuNoV infectivity and to determine whether Hu

87 icroarray analysis of Aag2 challenged with E.cloacae or infected with Dengue virus revealed high tran

88 Unlike wild-type (WT) forms, such as the E. cloacae P99 and Citrobacter freundii enzymes, the ES GC1

89 A library of Enterobacter cloacae P99 beta-lactamase mutants was produced to inves

90 cephalosporin hydrolysis by the Enterobacter cloacae P99 cephalosporinase (beta-lactam hydrolase, EC

91 tomyces sp. R61, a PBP, and the Enterobacter cloacae P99 cephalosporinase, a class C beta-lactamase.

92 f the class C beta-lactamase of Enterobacter cloacae P99 determined.

93 s the class C beta-lactamase of Enterobacter cloacae P99 in a covalent fashion.

94 h the class C beta-lactamase of Enterobacter cloacae P99 in two ways, by acylation and by phosphylati

95 drolysis by beta-lactamase from Enterobacter cloacae P99 indicated kcat values of 476 +/- 170 and 248

96 The class C beta-lactamase of Enterobacter cloacae P99 is closely similar in structure to the DD-pe

97 The class C beta-lactamase of Enterobacter cloacae P99 is competitively inhibited by low concentrat

98 lass C serine beta-lactamase of Enterobacter cloacae P99 is irreversibly inhibited by O-aryloxycarbon

99 r the class C beta-lactamase of Enterobacter cloacae P99 suggest an acyl-transfer transition state fo

100 The class C beta-lactamase of Enterobacter cloacae P99 was employed.

101 al class A (TEM-2) and class C (Enterobacter cloacae P99) beta-lactamases in a time-dependent fashion

102 y the class C beta-lactamase of Enterobacter cloacae P99, have been studied in order to more firmly e

103 etected Escherichia coli CMY-2, Enterobacter cloacae P99, Klebsiella pneumoniae ACT-1, and the AmpC b

104 d the class C beta-lactamase of Enterobacter cloacae P99.

105 milar class C beta-lactamase of Enterobacter cloacae P99.

106 f the class C beta-lactamase of Enterobacter cloacae P99.

107 ta-lactamases such as that from Enterobacter cloacae P99.

108 negative bacteria, specifically Enterobacter cloacae, Pseudomonas aeruginosa, and Pantoea agglomerans

109 production of DEX-specific Ab titers upon E. cloacae rechallenge.

110 robacter lignolyticus (formerly Enterobacter cloacae) SCF1 (enterolysin [ELY]).

111 pergillosis (20%, 3 of 15), and Enterobacter cloacae, Serratia marcescens, Pneumocystis carinii pneum

112 O157:H7, Klebsiella pneumoniae, Enterobacter cloacae, Shigella dysenteriae, Salmonella enterica, S. p

113 ulates LDs when challenged with Enterobacter cloacae, Sindbis, and Dengue viruses.

114 ane-bound selenate reductase of Enterobacter cloacae SLD1a-1 is purified in low yield and has relativ

115 he membrane-bound selenate reductase from E. cloacae SLD1a-1.

116 such as Klebsiella pneumoniae, Enterobacter cloacae, Stenotrophomonas maltophilia, and the Burkholde

117 Enterobacter cloacae strain G6809 with reduced susceptibility to carb

118 mase from a clinical isolate of Enterobacter cloacae strain GC1 with improved hydrolytic activity for

119 Shiga toxin 1 (Stx1)-producing Enterobacter cloacae strain, M12X01451, from a human clinical specime

120 erogenes and 13,954 isolates of Enterobacter cloacae tested using a Vitek system; for the same specie

121 iose-H(+) symporter (MelY) from Enterobacter cloacae that had enhanced fermentation on 1% maltose Mac

122 The adhesion of radiolabeled E. cloacae to HT-29 cells was concentration and temperature

123 es of endophthalmitis caused by Enterobacter cloacae: two in patients with acute postoperative endoph

124 The bacterial isolate was identified as E. cloacae using a polyphasic approach that included phenot

125 than the totals were noted with Enterobacter cloacae versus ampicillin-sulbactam, aztreonam, ticarcil

126 0(6) colony-forming units/mL of Enterobacter cloacae with the third feeding.